Applications of Chitosan in Dental Implantology - A Literature Review
Revathi Duraisamy1*, Dhanraj Ganapathy2, Rajeshkumar Shanmugam3
1 Senior Lecturer, Department of Prosthodontics and Implantology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai 600077, Tamil Nadu, India.
2 Professor and Head, Department of Prosthodontics and Implantology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai 600077, Tamil Nadu, India.
3 Associate Professor, Department of Pharmacology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai 600077, Tamil Nadu, India.
*Corresponding Author
Revathi Duraisamy,
Senior Lecturer, Department of Prosthodontics and Implantology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha
University, Chennai 600077, Tamil Nadu, India.
E-mail: revathid.sdc@saveetha.com
Received: August 16, 2021; Accepted: August 22, 2021; Published: August 23, 2021
Citation:Revathi Duraisamy, Dhanraj Ganapathy, Rajeshkumar Shanmugam. Applications of Chitosan in Dental Implantology - A Literature Review. Int J Dentistry Oral Sci. 2021;8(9):4140-4146. doi: dx.doi.org/10.19070/2377-8075-21000846
Copyright:Revathi Duraisamy©2021. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Abstract
Dental implants are commonly resorted treatment options for prosthetic rehabilitation of the missing tooth albeit being successful, the titanium implant surface exhibits poor bioactivity and antimicrobial properties, which could lead to primary and secondary early, implant failure. The unique properties of chitosan, a natural bioactive material, could be used as a coating for stabilization of the implant and the integration at the bone–biomaterial interface. It has received significant attention in the medical/dental field to explore its potential to enhance osseointegration function and clinical performance of the implant. This review aims to shed light on chitosan and their performance as a bioactive coating on implant surfaces.
2.Introduction
3.Conclusion
4.References
Keywords
Titanium Implant; Chitosan; Coating Surface; Functionalization; Osseointegration.
Abbreviations
kDa – Kilodalton; IL – Interleukin; Ti – Titanium; DDA – Degree Of Deacetylation; BMP – Bone Morphogenic
Protein; PMN - Polymorphonuclear Leukocytes; CaP – Calcium Phosphate Coating; MDA – Malondialdehyde;
HPX - Hydroxyproline; TNF a – Tumor Necrosis Factor – Alpha; PDGF- Platelet Derived Growth Factor; PGE2 – Prostaglandin
E2; MBC - Minimum Bactericidal Concentration; MAPLE - Matrix Assisted Pulsed Laser Evaporation; PBMT - Photobiomodulation
Therapy; HA - Hyaluronic Acid; CMCS - Carboxymethyl Chitosan; SBCS - Sulfated Benzaldehyde Chitosan;
GChi - Glycol-Chitosan; CAF - Cancer-Associated Fibroblast.
Introduction
Dental implants have revolutionized the prosthetic rehabilitation
of the tooth, overcoming the limitations of the fixed and removable
prosthesis [1]. Osseointegration is the principle behind the
longevity and clinical performance of the dental implant. The
concept of osseointegration was first put forth by Branemark [2].
The implant substrate gets integrated and has new bone formation
surrounding its surface. Over the course of months, about
60–70% of the implant surface is covered by bone. The amount
of bone-implant surface contact has been designated as %BIC.
This defines the amount of osseointegration percentage and
relies on macro and micro topography of the implant material,
type of alloy, design, size, surface texture and surgical implantation
technique, quality/quantity of the alveolar bone and occlusal
loading[3, 4]. Inspite of overly high success rates seen in implant
dentistry, commonly used material for implants are titanium (Ti),
due to their biocompatibility. However, they do have an effect on
their on the implant surface and are not resistant to bacterial attacks
which may over a duration of time leads to primary and secondary
implant failure such as poor osseointegration, mechanical
problems, immobilization, poor oral hygiene, systemic complications,
and infection [5]. In order to overcome the limitations, various
efforts have been undertaken, including coating the implant
surface to enhance their clinical performance is long been thought
to enhance osseointegration by mediating the direct interaction to
host osteoblasts in bone formation.
Materials used in dentistry are at a constant phase of evolution,
overcoming their existing limitations. Naturally derived biomaterials
have excellent properties such as biodegradability, biocompatibility
and non-toxic profile, which makes them an ideal substances.
Such materials should resemble extra cellular matrix in order
to emulate their osteogenic and physiological function. Some of
the bioactive materials that have been investigated include starch,
collagen, gelatin, alginate, cellulose, elastin and chitosan [6, 7]. Incorporating
chitosan represents an ideal choice to enhance their
performance. The osteoconductive and osteoinductive property,
anti-inflammatory, anti-bacterial and wound repairing mechanism
have rendered them to be an ideal coating to enhance bone formation
and to prolong the longevity of orthopedic and dental
implant devices [8]. In this review, we discuss the latest application
of chitosan coating on dental implants.
Chitosan
Chitosan was first reported by Rougat in 1859 is a cationic polysaccharide
is made up of ß-(1-4)-linked d-glucosamine and Nacetyl-
d-glucosamine in repeated units [9]. It was first detected in
the exoskeleton of sea creatures such as shrimp, crabs. Chitosan is
the most widely present polysaccharide after cellulose. Apart from
marine sources, chitosan can also be extracted from fungi namely,
Aspergillus spp., Rhizopus. Gongronella spp., Absidia spp., as they are
known to harbor chitosan as their primary cell wall component
[10].
Chitin is the raw form of chitosan, is treated to demineralization,
deproteinization and decolourization using chemical reagents.
Chitin is deacetylated to chitosan. The raw material is a translucent,
resilient, highly organized crystalline structure with poor reactivity
and low solubility in the aqueous medium. To make them
suitable for various applications, the reactive hydroxyl group is
chemically modified through carboxymethylation, etherification,
Quaternization and precipitation or flocculation. These modifications
impart more stability, solubility, lower toxicity and less
inflammatory properties [12]. The method of extraction of chitosan
determines the degree of deactelyation, and is given by the
ratio of GlcNAc to GlcN structural units is an important criterion
influencing the physical property such as solubility, viscosity
and absorption. The degree of deacetylation confers the molecular
weight of the chitosan biomaterials. They could range from
low molecular weight (50–190 kDa), medium molecular weight
(190–300 kDa) and high molecular weight (310–375 kDa).
Chitosan has been employed as a carrier for drugs, proteins, vaccines
through nanoparticles in the biomedical field due to their
excellent biocompatibility, non-toxicity, hemostatic, mucoadhesive,
antitumor, antioxidant, and antimicrobial properties. The
common usage of chitosan in the field of dentistry is given in
Table 1.
The coated material on the implant surface should have the potential
to withstand heavy masticatory forces. As, the when exceeding
the threshold limit, the stress results in delamination and
disintegration of the coating along the implant-bone surfaces
[46]. Chitosan does not adhere to the implant surface due to its
lack of surface reactivity, so they are applied to the implant surfaces
in combination with different polymer compounds to amplify
the surface conductivity. The optimization of bioactive chitosan
coatings requires the intricate knowledge of the mechanisms influencing
bioactivity, surface properties, and bonding strength to
titanium implants.
Coating of Chitosan
Silanization
Silanes are chemical compounds that oxidize the implant surface
leaving it rich in hydroxyl groups, this enables the chitosan to
chemically bond with implant surfaces to increase coating– substrate
fracture resistance. Commonly employed silane chemicals
include 3-Aminopropyltriethoxysilane (APTES), isocyantopropyltriethoxysilane
(ICPTES) and triethoxysylilbutyraldehyde
(TESBA) [47]. The compound reacts with glutaraldheyde groups
of the chitosan molecule forming a covalent bond strength of
1.5–1.8 MPa [48]. Ethanol and water due to relatively harmless
profile have been examined in deposition of APTES/Chitosan
on implant surfaces. It was found that bond strength had significantly
increased from mean 0.5 MPa for chitosan simply absorbed
to the titanium to 1.5 MPa [49].
Greene et al. used the APTES–glutaraldehyde to coat chitosan
onto a 316L stainless steel screw via a dip-coating process. They
screwed chitosan-coated screws into solid rigid polyurethane foam simulating the density of bone and showed that approximately
90% of the chitosan coating was retained even in hydrated
conditions, based on change in mass [50].
Ethylene oxide gas sterilization, DDA of the chitosan, 2% gentamicin
in the chitosan solution on titanium or stainless steel surfaces
have been explored to increase the bond strength47. Due to
the crystalline structure of the chitosan, Nano-indentation methods
have been used by Wang SF et al and Majd S et al to investigate
the bond strength of chitosan films, however it did not have
a significant effect [51, 52]. Martin et al investigated toluene added
to APTES onto titanium samples, to increase the bond strength
of the chitosan coating to titanium, they observed that the bond
strength more than tenfold as compared to the ethanol/water-deposited
APTES. This increase in bond strength was attributed to
increased silane deposition with toluene solvent as compared to
ethanol/water solvent, as measured by X-ray photoelectron spectroscopy
[53]. Renoud P et al demonstrated that chitosan coated
surfaces were scratch resistant with strong adhesive properties.
When tested for bacterial resistance, they showed strong inhibition
of Actinomyces naeslundii growth and good biocompatibility to
fibroblasts [54].
Electrodeposition
In this method, an electrical current is utilized to deposit charged
material from a conductive solution onto a target surface (the implant
surface). Electrodeposition of chitosan particle is relatively
inexpensive and allows control of the thickness of the coating on
the implant surface [55]. Coatings produced from electrodeposition
are dependent on electrolytic medium, the electrical nature
of electrodes, particle charge, particle size, and viscosity of the
suspension along with the applied electric field [56]. The pH of
the suspension affects the particle charge distribution and ionic
conductivity of the suspension, which in turn affects the electrophoretic
mobility of the particles.
Sputter coated chitosan-calcium phosphate and uncoated titanium
pins in a 12-week rabbit model when examined histologically,
showed new bone formation and accelerated healing of implant
wounds which were identical to the results obtained from controls
samples which were uncoated [57]. Electrodeposited CaP/
chitosan coatings were found to favour osteoblast differentiation
and proliferation from MC3T3-E1 cells, which may endow them
with great potential for future application [58].
Panda S et al in 2019, studied the osseointegrative properties of
pure Ti-6Al-4V substrates with three different surface roughness (1.1, 1.9 and 3.1 µm) coated with chitosan and bovine serum albumin
successfully by using sol-gel dip coating and electrophoretic
deposition (EPD) methods. The coating produced a better coating
stability over the Ti substrate than sol-gel dip coating and Chi-
BSA conjugate coating demonstrated higher stability and surface
texture than only Chitosan coating [59].
Degree of deacetylation was modified and a 91.2% de-acetylated
chitosan did not affect the bond strength (1.5-1.8 MPa) when they
were sterilized using gas. There was a mild dissolution in the coatings
surfaces that were sterilized with gas and the growth of the
osteoblast cells was greater on the chitosan-coated samples than
on the uncoated titanium. These results indicated that chitosan
promotes osteoblast proliferation more than the controls [48].
The latest innovative technique that used for chitosan deposition
is the physical vapor deposition method, where a dilute frozen
solution of the coating material is vaporized using a pulsed laser.
The vapor from the solvent material absorbs the energy of the
laser, and is volatilized along with the coating material. The larger
vapour molecules are deposited rapidly on the substrate surface.
The process provides excellent control over several film coating
parameters, including thickness, roughness, and homogeneity.
Patz et al. used this technique, matrix assisted pulsed laser evaporation
(MAPLE) to coat chitosan onto a titanium wire mesh. The
MAPLE chitosan coating showed high coating uniformity on the
mesh (demonstrating the ability to coat complex shapes and internal
surfaces) and compatibility with cultured bone cells [60].
Layer-by-layer self-assembly techniques have also been used to
make chitosan coatings. This technique forms multilayers on the
titanium surfaces. A layer of positively charged material (chitosan)
is first induced followed by alternate deposition of negatively
charged Gel and positively charged material utilizing electrostatic
interactions [61]. The technique is a relatively low cost,
simple technique that can be performed with minimal equipment
at room temperature. The method takes advantage of the static
or hydrogen-bond interactions between different kinds of macromolecules.
The process results in very thin membranes and
coatings that retain the original and desirable properties of the
component polymers such as heparin, hyaluronic acid, oxy-chitin,
gelatin, and bioglass particles [62].
Thickness and Concentration of Chitosan Coating
The thickness of the biomaterial coating also plays a significant
role in osseointegration. A adequate thickness of the coating is
around 30-40 µm, which degraded only after 52 weeks and it exhibited
better early bone apposition without any inflammation
signs [71]. The smooth surfaces of chitosan microspheres does
not show any features for cell attachment. Therefore it was combined
with ß-TCP to form a ß-TCP/chitosan composite microspheres.
It was then seeded with murine MC3T3-E1 osteoblasts
for evaluating the attachment interaction between cells and materials.
It was observed that the adherence and proliferation of
osteoblastic cells were significantly better than on chitosan microsphere
alone [72].
Chitosan combined with strontium ranelate was evaluated for
their bone regenerating capacity on titanium surface in different
concentrations of strontium ranelate (SR) (0, 2, 20, 40, and 80
mmol/L of the strontium ion [Sr2+]). SR-loaded chitosan film
on a titanium surface promoted significant osteoblast proliferation
and differentiation in a dose-dependent manner, this could
potentially a new treatment for cases where the quality/quantity
of the alveolar bone is in question [73].
A complex of a chitosan/collagen coating was hypothesized to
promote gingival epithelial cell adhesion to titanium implants
conditioned with plasmid pLAMA3-CM. Ne epithelial attachment
was seen at the end of the study which were confirmed
through immunofluorescence studies. The authors concluded
that modification of titanium implants by plasmid-mediated pLAMA3-
CM diffusion is an optimistic method to create a biological
seal around the transmucosal sites of implants. A novel implant
substrate was developed containing graphene–chitosan has been
demonstrated to show increased surface wettability and roughness,
thereby upregulating osteoblast proliferation [74].
Chitosan Degradation
The degradation rate describes the reduction of chitosan layers/
films caused by enzymes, lysozymes and free radicals. The amount
of lysozyme can be used to determination of chitosan degradation
rates. To gain long term mechanical stability, coating material
should exhibit optimal degradation behavior and match the speed
of the new tissue formation [75] Ma K et al observed that chitosan-
gelatin coating degraded completely after 28 weeks through
which it was found to be more stable [76]. However, since Chitosan
is sensitive to mild changes in the pH of the solution, alkaline
buffer solutions such as phosphate-buffered saline (PBS)
tends to degrade chitosan faster than usual [77]. The in vivo study
of Wang J et al. also demonstrated the stability of chitosan from
degradation after 26 weeks and 12 weeks [71].
Bioactivity Of Chitosan Coating
Cellular behavior is influenced by the surface characteristics and
DD, with distinct effects depending on the cell type. Osteoblastic
cell attachment and proliferation are favored on high DD chitosan
membranes, which aid in the differentiation process and
stimulate the secretion of extracellular matrix proteins. Chitosan
coated implant surface are positively charged which attracts the
negatively charges red blood corpuscles, cytokines, hormones and
a plethora of growth factors to the site of implantation and orchestrates
tissue repair and remodeling [63]. Absorption of chitosan
coating onto the surface of the implant paved the way for
the coating to be used for drug delivery, incorporation of growth
factors [64]. Chitosan films and coatings sustain osteoblastic cell
growth and act as a vehicle for growth factors, bone morphogenetic
protein (BMP), release of BMP with as much as 80–85% of
the BMP being retained in the films after 7 days [65].
Greene et al. employed a double trypsinization method to collect
normal human fibroblasts and cells from a human osteoblastic
precursor cell line from chitosan coatings bonded to stainless steel
as compared to uncoated stainless steel coupons. Their results
showed that both the fibroblasts and osteoprecursor cells grew
equally well on the chitosan coatings as on the uncoated controls
[50].
The osteogenic potential of chitosan coating was studied by Zujur
D et al in 2015, who chemically modified the chitosan through
lactobionic and 4-azidebenzoic acid to convert it to a hydrogel
and photocrosslinkable. It was then treated to the pure Ti alloys
sandblasted with alumina particles. The coating had sustained able
to support cell proliferation of osteoblasts and could be used for
further studies in the encapsulation of bioactive molecules to improve
osteogenic potential at the tissue-implant interface [66].
Norowski et al in 2011 incorporated tetracycline at 20 wt% or
the antimicrobial chlorhexidine at 0.02 wt% of coatings made
with an 81% DDA chitosan bonded to titanium. They found that
chitosan coatings released 89% of the tetracycline in 7 days and
100% chlorhexidine in 2 days in vitro. Released tetracycline inhibited
the growth (95–99.9%) of Actinobacillus actinomycetemcomitans
and Staphylococcus epidermidis for up to 7 days with no cytotoxicity
to human fiboroblastic or osteoblastic cells [67].
Leedy et al in 2009 loaded vascular endothelial growth factor in
chitosan coatings bonded to titanium via to assess the osseointegration
via local stimulation of angiogenesis, in patients on bisphosphonate
therapies for osteoporosis or myeloid cancer. The
growth factor had rapidly released over 3 days from coatings with
an initial peak of ~44 ng/mL/cm2 at day 1 and 0.15 ng/mL/cm2
at day 3. The growth-factor-loaded coatings enhanced the viability
of endothelial cells and significantly stimulated the proliferation
of osteoblastic cells in vitro [68].
Wang et al. used a chitosan-plasmid DNA coated titanium screws
to which type-IV collagen was applied in order to mimic extra
cellular matrix environment. The authors observed significant
new tissue attachment surrounding the dental implants [69]. Electrodeposited
calcium hydroxide particles and chitosan coatings in
Ti6Al4V plates to stimulate osteoblast function and osteogenesis.
They found an increase in alkaline phosphatase activity, collagen
expression and both bone sialoprotein and osteocalcin genes were
up-regulated on cells that were cultured on the electrodeposited
CaP/chitosan coatings [58].
Chen et al assessed the antioxidant and osteogenic capacity of
a multilayer surface on Ti substrates (Chitosan was combined
with catechol and compared against coatings of gelatin, and
hydroxyapatite on their capacity to form multilayer bioactive
coatings, it was found that chitosan coating along with catechol
displayed multilayered coating on the implant surface which in
turns promoted Ti implants were able to promote osteogenesis
through upregulation of osteoblast-related gene expression.[70]
Klokkevold et al. reported that chitosan films facilitated the differentiation
of osteoprogenitor cells, and inhibited fibroblast proliferation
[78]. More recently, Lahiji et al. demonstrated that osteoblasts
maintained phenotypic morphology and expression of
extracellular matrix proteins for seven days when cultured on 90%
de-acetylated chitosan films as compared to plastic coverslips [79].
A conglomeration of chitosan- hydroxyapatite hydrogels were
produced by a thermal cross-linking reaction using glycerol phosphate
disodium salt coated on 316L SS implants were found to
increase osseointegration biocompatibility and protection against
corrosion. Recently, CS has been utilized in 3D printing for various
tissue engineering applications [80].
Immediate loading implants after tooth extraction is an attractive
alternative that presents several advantages such as reduction
of post-extraction resorption, optimal positioning of the implant
and reduction of the time required for prosthetic rehabilitation.
On, which requires a prerequisite of adequate bone volume.
Several regenerative treatment modalities, such as guided tissue
regeneration (GTR) and autogenous bone grafting (autografts),
have already been introduced into clinics, and been unequivocally
accepted as the standard of care.
An in-vitro study by Alnufaiy BM et al in 2020 investigating the osteogenic
potential of chitosan coated implant surface by altering
the degree of deacetylation to 80 or 95 DDA% in hMSC-TERT
20 cells It was observed that all cells exhibited significant attachement
although it was higher in 95% along with a significant
increase in the expression of osteogenic markers compared to
the 80% chitosan and control groups. The biomineralization and
enhanced osseointegrative function of high DDA of was justified
and is thought to enhance future dental implant healing processes
and osseointegration [81]. Zhang Y et al in 2017 constructed chitosan/
collagen composites combined with virus encoding BMP7
gene by freeze-drying methods demonstrated the osteogenesis induced
by chitosan/collagen combined with BMP7 [82].
Murine mandibles were implanted with chitosan/GNP/GFBP-
3 coating for 4 weeks. Histopathology revealed enhanced bone
remodeling and increase in bone density around the implant. The
authors suggested that the coating had down-regulating osteoclastogenesis
and up-regulating osteogenesis [83]. The same author
also examined the role of chitosan/ Peroxisome proliferator activated
receptor gamma around implants and observed a significant
reduction of pro-inflammatory mediators and upregulation of
osteoblastic gene expression which reinforced the bone–implant
integration [84]. Lactose-modified chitosan coating for implants
in minipig femur model by Marsich et al reported evidence of
anti-inflammatory and antioxidant effects of chitosan and lactose
scaffold on chondrocytes [85].
Although favorable results were obtained from animal models,
in-vitro conditions. These results cannot be extrapolated to the environment
of human oral cavity, where dynamic factors might
influence the chitosan coating pertaining to implantology since
cortical remodeling is absent and they stop growing later than
other mammals. Future research should be aimed to assess if such
coatings would sustain and facilitate osseointegration within the
harsh environment of human beings.
Table 1. This table shows the prevalence of different types of RRR with relation to age, gender and the history of denture usage.
Conclusion
Chitosan has attracted considerable attention in dentistry due to
its strong favours. This novel bioactive coating of chitosan can
produce robust titanium surfaces with greater osseointegration
capacity than uncoated titanium alloys. The quality and quantity
of bone formation surrounding the implant surfaces can be increased
by using chitosan along with other polymer compounds
of mineralization substantially increased with an increased number
of bi-layers.
References
-
[1]. Pepla E, Besharat LK, Palaia G, Tenore G, Migliau G. Nano-hydroxyapatite
and its applications in preventive, restorative and regenerative dentistry: a
review of literature. Ann Stomatol (Roma). 2014 Nov 20;5(3):108-14.Pubmed
PMID: 25506416.
[2]. Kim HJ, Mo SY, Kim DS. Effect of Bioactive Glass-Containing Light- Curing Varnish on Enamel Remineralization. Materials (Basel). 2021 Jul 4;14(13):3745.Pubmed PMID: 34279316.
[3]. Taecha-Apaikun K, Pisek P, Suwanprateeb J, Thammarakcharoen F, Arayatrakoollikit U, Angwarawong T, et al. In vitro resorbability and granular characteristics of 3D-printed hydroxyapatite granules versus allograft, xenograft, and alloplast for alveolar cleft surgery applications. Proc Inst Mech Eng H. 2021 Jul 21:9544119211034370.Pubmed PMID: 34289764.
[4]. Bordea IR, Candrea S, Alexescu GT, Bran S, Baciu? M, Baciu? G, et al. Nano-hydroxyapatite use in dentistry: A systematic review. Drug Metab. Rev. 2020 Apr 2;52(2):319-32.
[5]. Watcharajittanont N, Tabrizian M, Putson C, Pripatnanont P, Meesane J. Osseointegrated membranes based on electro-spun TiO2/hydroxyapatite/ polyurethane for oral maxillofacial surgery. Mater Sci Eng C Mater Biol Appl. 2020 Mar;108:110479.Pubmed PMID: 31923963.
[6]. Muzzarelli RA, El Mehtedi M, Bottegoni C, Aquili A, Gigante A. Genipin- Crosslinked Chitosan Gels and Scaffolds for Tissue Engineering and Regeneration of Cartilage and Bone. Mar Drugs. 2015 Dec 11;13(12):7314-38. Pubmed PMID: 26690453.
[7]. Wu Y, Li Q, Xu B, Fu H, Li Y. Nano-hydroxyapatite coated TiO2 nanotubes on Ti-19Zr-10Nb-1Fe alloy promotes osteogenesis in vitro. Colloids Surf B Biointerfaces. 2021 Aug 2;207:112019.Pubmed PMID: 34388611.
[8]. Ma P , Chen T , Wu X , Hu Y , Huang K , Wang Y , et al. Effects of bioactive strontium-substituted hydroxyapatite on osseointegration of polyethylene terephthalate artificial ligaments. J Mater Chem B. 2021 Sep 7;9(33):6600- 6613. doi: 10.1039/d1tb00768h. Epub 2021 Aug 9. Pubmed PMID: 34369537.
[9]. Amaechi BT, Phillips TS, Evans V, Ugwokaegbe CP, Luong MN, Okoye LO, et al. The Potential of Hydroxyapatite Toothpaste to Prevent Root Caries: A pH-Cycling Study. Clin Cosmet Investig Dent. 2021 Jul 21;13:315-324. Pubmed PMID: 34321930.
[10]. Hsu SM, Alsafadi M, Vasconez C, Fares C, Craciun V, O'Neill E, et al. Qualitative Analysis of Remineralization Capabilities of Bioactive Glass (NovaMin) and Fluoride on Hydroxyapatite (HA) Discs: An In Vitro Study. Materials (Basel). 2021 Jul 8;14(14):3813.Pubmed PMID: 34300732.
[11]. Poon TKC, Iyengar KP, Jain VK. Silver Nanoparticle (AgNP) Technology applications in trauma and orthopaedics. J Clin Orthop Trauma. 2021 Jul 27;21:101536. Pubmed PMID: 34386347.
[12]. Mulazzi M, Campodoni E, Bassi G, Montesi M, Panseri S, Bonvicini F, et al. Medicated Hydroxyapatite/Collagen Hybrid Scaffolds for Bone Regeneration and Local Antimicrobial Therapy to Prevent Bone Infections. Pharmaceutics. 2021 Jul 16;13(7):1090.Pubmed PMID: 34371782.
[13]. Murugan S, Parcha SR. Fabrication techniques involved in developing the composite scaffolds PCL/HA nanoparticles for bone tissue engineering applications. J Mater Sci Mater Med. 2021 Aug 11;32(8):93.Pubmed PMID: 34379204.
[14]. Ghammraoui B, Zidan A, Alayoubi A, Zidan A, Glick SJ. Fabrication of microcalcifications for insertion into phantoms used to evaluate x-ray breast imaging systems. Biomed. Phys. Eng. Express. 2021 Aug 10.
[15]. Prabakaran S, Rajan M, Geng Z, Liu Y. Fabrication of substituted hydroxyapatite- starch-clay bio-composite coated titanium implant for new bone formation. Carbohydr Polym. 2021 Nov 1;271:118432.Pubmed PMID: 34364572.
[16]. Chang YL, Hsieh CY, Yeh CY, Chang CH, Lin FH. Fabrication of Stromal Cell-Derived Factor-1 Contained in Gelatin/Hyaluronate Copo006Cymer Mixed with Hydroxyapatite for Use in Traumatic Bone Defects. Micromachines (Basel). 2021 Jul 14;12(7):822.Pubmed PMID: 34357232.
[17]. Anita Lett J, Sagadevan S, Léonard E, Fatimah I, Motalib Hossain MA, Mohammad F, et al. Bone tissue engineering potentials of 3D printed magnesium- hydroxyapatite@ polylactic acid composite scaffolds. Artif. Organs. 2021 Jul 26.
[18]. Ando A, Kamikura M, Takeoka Y, Rikukawa M, Nakano K, Nagaya M, et al. Bioresorbable porous ß-tricalcium phosphate chelate-setting cements with poly(lactic-co-glycolic acid) particles as pore-forming agent: fabrication, material properties, cytotoxicity, and in vivo evaluation. Sci Technol Adv Mater. 2021 Jun 24;22(1):511-521.Pubmed PMID: 34220339.
[19]. Samirah, Budiatin AS, Mahyudin F, Khotib J. Fabrication and characterization of bovine hydroxyapatite-gelatin-alendronate scaffold cross-linked by glutaraldehyde for bone regeneration. J Basic Clin Physiol Pharmacol. 2021 Jun 25;32(4):555-560.Pubmed PMID: 34214349.
[20]. Kilic M, Gurbuz T. Evaluation of the effects of different remineralisation agents on initial enamel lesions by scanning electron microscope and energydistributed X-ray analysis. Int J Clin Pract. 2021 Aug;75(8):e14299.Pubmed PMID: 33930242.
[21]. Paszynska E, Pawinska M, Gawriolek M, Kaminska I, Otulakowska-Skrzynska J, Marczuk-Kolada G, et al. Impact of a toothpaste with microcrystalline hydroxyapatite on the occurrence of early childhood caries: a 1-year randomized clinical trial. Sci Rep. 2021 Jan 29;11(1):2650. Pubmed PMID: 33514787.
[22]. AbouAitah K, Bil M, Pietrzykowska E, Szalaj U, Fudala D, Wozniak B, et al. Drug-Releasing Antibacterial Coating Made from Nano-Hydroxyapatite Using the Sonocoating Method. Nanomaterials (Basel). 2021 Jun 28;11(7):1690. Pubmed PMID: 34203218.
[23]. Zhang W, Zhou R, Yang Y, Peng S, Xiao D, Kong T, et al. Aptamer-mediated synthesis of multifunctional nano-hydroxyapatite for active tumour bioimaging and treatment. Cell Prolif. 2021 Aug 12:e13105.Pubmed PMID: 34382270.
[24]. Liang W, Ding P, Li G, Lu E, Zhao Z. Hydroxyapatite nanoparticles facilitate osteoblast differentiation and bone formation within sagittal suture during expansion in rats. Drug Des Devel Ther. 2021;15:3347–8.
[25]. Sathe N, Chakradhar RR, Chandrasekhar V. Effect of three different remineralizing agents on enamel caries formation–an in vitro study. Kathmandu Univ Med J. 2014;12(1):16-20.
[26]. Burtscher S, Krieg P, Killinger A, Al-Ahmad A, Seidenstücker M, Latorre SH, et al. Thin Degradable Coatings for Optimization of Osteointegration Associated with Simultaneous Infection Prophylaxis. Materials (Basel). 2019 Oct 25;12(21):3495.Pubmed PMID: 31731410.
[27]. Pandey A, Midha S, Sharma RK, Maurya R, Nigam VK, Ghosh S, et al. Antioxidant and antibacterial hydroxyapatite-based biocomposite for orthopedic applications. Mater Sci Eng C Mater Biol Appl. 2018 Jul 1;88:13-24. Pubmed PMID: 29636127.
[28]. Chirica IM, Enciu AM, Tite T, Dudau M, Albulescu L, Iconaru SL, et al. The Physico-Chemical Properties and Exploratory Real-Time Cell Analysis of Hydroxyapatite Nanopowders Substituted with Ce, Mg, Sr, and Zn (0.5-5 at.%). Materials (Basel). 2021 Jul 8;14(14):3808. Pubmed PMID: 34300727.
[29]. Damerau JM, Bierbaum S, Wiedemeier D, Korn P, Smeets R, Jenny G, et al. A systematic review on the effect of inorganic surface coatings in large animal models and meta-analysis on tricalcium phosphate and hydroxyapatite on periimplant bone formation. J Biomed Mater Res B Appl Biomater. 2021 Jul 16.Pubmed PMID: 34272804.